<DOC>
	<DOCNO>NCT02786095</DOCNO>
	<brief_summary>This study prospective Cohort study perform multicenter ( General Hospital ) Korea . Inclusion criteria patient atrial fibrillation visit hospital . The purpose analyze complication , composite outcome ( cause mortality , hospitalization , incidence stroke , heart failure cardiovascular event ( MACE ) ) accord 1 ) use anti-arrhythmic drug ( AADs ) , 2 ) use medication rate control ( beta blocker , calcium channel blocker digoxin ) 3 ) use anticoagulation agent ( warfarin , coumadin , NOAC )</brief_summary>
	<brief_title>Comparison Study Drugs Symptom Control Complication Prevention Atrial Fibrillation ( AF ) ( Code-AF Trial )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>patient atrial fibrillation patient age 19 patient agree study inclusion patient agree study inclusion patient age le 19 Pregnancy , Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>anti arrhythmic drug</keyword>
	<keyword>NOAC</keyword>
	<keyword>warfarin</keyword>
	<keyword>coumadin</keyword>
</DOC>